These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34120233)

  • 1. Response to letter to the editor and comment concerning "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
    Zhang L; Li Y; Liu D; Jiao G; Wu W; Wang H; Liu H; Chen Y
    Int Orthop; 2021 Aug; 45(8):2167-2168. PubMed ID: 34120233
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
    Zhang D; Wu H; Kong Q
    Int Orthop; 2021 May; 45(5):1365-1366. PubMed ID: 33619585
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial".
    Dong H; Lu Y; Luo Y
    Int Orthop; 2021 Jul; 45(7):1903-1904. PubMed ID: 33829306
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial.
    Zhang L; Li Y; Liu D; Xiao X; Guan T; Yue H; Xue H; Zhou H; Jiao G; Wu W; Wang H; Liu H; Meng C; Sun Z; Chen Y
    Int Orthop; 2020 Oct; 44(10):2079-2087. PubMed ID: 32676780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of tranexamic acid sequential rivaroxaban on blood loss in elderly patients during lumbar interbody fusion].
    Yang X; Hao D; Wang X; Gao W; Hui H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Sep; 34(9):1158-1162. PubMed ID: 32929910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis.
    Kim YT; Kang MW; Lee JK; Lee YM; Kim JI
    BMC Musculoskelet Disord; 2018 Jul; 19(1):227. PubMed ID: 30021575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial.
    Wang JW; Chen B; Lin PC; Yen SH; Huang CC; Kuo FC
    J Arthroplasty; 2017 Mar; 32(3):801-806. PubMed ID: 27663190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy and Safety of Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Patients Treated with Posterior Lumbar Interbody Fusion.
    Sun H; Deng L; Deng J; Wang J; Zhang H; Chen K; Li H; Ning X; Yang H
    World Neurosurg; 2019 May; 125():e198-e204. PubMed ID: 30684701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
    Clavé A; Fazilleau F; Dumser D; Lacroix J
    Orthop Traumatol Surg Res; 2012 Sep; 98(5):484-90. PubMed ID: 22542983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor. Tranexamic acid for reducing intra- and postoperative blood loss in posterior lumbar interbody fusion: Is it safe enough?
    Li YS; Chen CY; Chen CH; Yao ZK; Sung YH; Lin KC; Tarng YW; Hsu CJ; Renn JH
    J Neurosurg Spine; 2018 Aug; 29(2):226-227. PubMed ID: 29701567
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion.
    Kushioka J; Yamashita T; Okuda S; Maeno T; Matsumoto T; Yamasaki R; Iwasaki M
    J Neurosurg Spine; 2017 Mar; 26(3):363-367. PubMed ID: 27885960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis.
    Gong M; Liu G; Chen L; Chen R; Xiang Z
    World Neurosurg; 2019 Feb; 122():559-568. PubMed ID: 30336299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Use of Tranexamic Acid and Rivaroxaban in Posterior/Transforaminal Lumbar Interbody Fusion Surgeries Safely Reduces Blood Loss and Incidence of Thrombosis: Evidence From a Prospective, Randomized, Double-Blind, Placebo-Controlled Study.
    Li X; Jiao G; Li J; Ji W; Hao Z; Gong F; Chen Y
    Global Spine J; 2023 Jun; 13(5):1229-1237. PubMed ID: 34569334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Administration of Tranexamic Acid Significantly Reduces Visible and Hidden Blood Loss Compared with Its Topical Administration for Double-Segment Posterior Lumbar Interbody Fusion: A Single-Center, Placebo-Controlled, Randomized Trial.
    Mu X; Wei J; Wang C; Ou Y; Yin D; Liang B; Qiu D; Li Z
    World Neurosurg; 2019 Feb; 122():e821-e827. PubMed ID: 30391759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial.
    Shi H; Ou Y; Jiang D; Quan Z; Zhao Z; Zhu Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5718. PubMed ID: 28072709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China
.
    Hu KZ; Sun HY; Sui C
    Int J Clin Pharmacol Ther; 2017 May; 55(5):433-441. PubMed ID: 28139973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Topical Administration of Tranexamic Acid in High-Risk Patients Undergoing Posterior Lumbar Interbody Fusion Surgery.
    Shi P; Wang J; Cai T; Chen D; Wang S; Feng X; Wang Y; Zhang W; Zhang L
    World Neurosurg; 2021 Jul; 151():e621-e629. PubMed ID: 33940262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
    Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
    Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 3 different anticoagulants on hidden blood loss during total hip arthroplasty after tranexamic acid.
    Deng ZF; Zhang ZJ; Sheng PY; Fu M; Xu DL; He AS; Liao WM; Kang Y
    Medicine (Baltimore); 2020 Sep; 99(36):e22028. PubMed ID: 32899057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
    Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
    Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.